Between Management, BOD and the "friendly" shares
Post# of 36536
Too bad a public company has to be ran this way, current style reminds me of a private company, poor decisions are justified ........ it was the only option !!!
Unless clear communication regarding company status, funding, future Revenue estimates , GNBT/NGIO/NGUX listing , Merck/AE37 trial , Altucell, dividend split NGIO/NGUX trading clarification, China IP sharing status, Vaccine update including target time-line for Mass Production, current employees/salaries etc .......ALL assumptions are valid.
Wonder whatever happened with
Quantum Lifesciences, Inc ..... another potential public company??
Exciting times ahead.